25 May 2013
Keywords: novartis, money-back, campaign, diovan, swiss, drug, major
Article | 03 May 2004
Swiss drug major Novartis has unveiled a novel marketing initiative in the very competitive US market for its top-selling antihypertensive ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
3 May 2004
24 May 2013
© 2013 thepharmaletter.com